These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7571535)

  • 1. [Dopaminomimetic psychosis].
    Ilić T; Marić D; Ivanisević V; Magdić B
    Vojnosanit Pregl; 1995; 52(2):184-8. PubMed ID: 7571535
    [No Abstract]   [Full Text] [Related]  

  • 2. [Toxic and adverse neurological effects of anti-parkinsonian drugs].
    Sunohara N
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):527-31. PubMed ID: 10434715
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dopaminomimetic psychosis in Parkinson's disease: first symptom of early dementia?].
    Catalan-Alonso MJ; Del Val J
    Rev Neurol; 2001 Jun 1-15; 32(11):1085-7. PubMed ID: 11562835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zotepine in levodopa-induced Psychosis.
    Spieker S; Stetter F; Klockgether T
    Mov Disord; 1995 Nov; 10(6):795-7. PubMed ID: 8750001
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
    Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS
    Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine.
    Normann C; Hesslinger B; Frauenknecht S; Berger M; Walden J
    Pharmacopsychiatry; 1997 Nov; 30(6):263-5. PubMed ID: 9442549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine prevents recurrence of psychosis in Parkinson's disease.
    Factor SA; Brown D
    Mov Disord; 1992; 7(2):125-31. PubMed ID: 1350059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology of levodopa-induced dyskinesia in parkinsonian patients.
    Rascol O; Brefel-Courbon C; Descombes S; Montastruc JL
    Adv Neurol; 1999; 80():485-90. PubMed ID: 10410760
    [No Abstract]   [Full Text] [Related]  

  • 9. Levodopa addiction in idiopathic Parkinson disease.
    Borek LL; Friedman JH
    Neurology; 2005 Nov; 65(9):1508. PubMed ID: 16275855
    [No Abstract]   [Full Text] [Related]  

  • 10. What to do when Sinemet fails: Part one.
    Klawans HL
    Clin Neuropharmacol; 1984; 7(2):121-33. PubMed ID: 6733692
    [No Abstract]   [Full Text] [Related]  

  • 11. Levodopa addiction in non-parkinsonian patients.
    Steiner I; Wirguin I
    Neurology; 2003 Nov; 61(10):1451. PubMed ID: 14638980
    [No Abstract]   [Full Text] [Related]  

  • 12. Addiction as aberrant learning-evidence from Parkinson's disease.
    Dagher A
    Addiction; 2012 Feb; 107(2):248-50. PubMed ID: 22248132
    [No Abstract]   [Full Text] [Related]  

  • 13. [Levodopa-induced psychosis in patients with idiopathic Parkinson disease].
    García-Escrig M; Bermejo Pareja F; Fernández Ponsatí JT
    Med Clin (Barc); 1999 Feb; 112(7):245-50. PubMed ID: 10220750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine: a proarrhythmic drug?
    Gupta N; Malhotra P
    Can J Psychiatry; 2002 Sep; 47(7):683-4. PubMed ID: 12355682
    [No Abstract]   [Full Text] [Related]  

  • 15. Stimulating debate in the field of addiction.
    Carter A; Hall W; Ambermoon P; Dissanayaka N; O'Sullivan J
    Addiction; 2012 Feb; 107(2):253. PubMed ID: 22248135
    [No Abstract]   [Full Text] [Related]  

  • 16. Involvement of serotonin in clinical features of Parkinson's disease and complications of L-DOPA therapy.
    Melamed E; Zoldan J; Friedberg G; Ziv I; Weizmann A
    Adv Neurol; 1996; 69():545-50. PubMed ID: 8615179
    [No Abstract]   [Full Text] [Related]  

  • 17. [Exogenous psychoses in Parkinson syndrome. Frequency and causal conditions].
    Schneider E; Fischer PA; Jacobi P; Grotz A
    Fortschr Neurol Psychiatr; 1984 Jun; 52(6):207-14. PubMed ID: 6745832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of drug-induced psychosis in Parkinson's disease with clozapine.
    Greene P; Cote L; Fahn S
    Adv Neurol; 1993; 60():703-6. PubMed ID: 8420214
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders.
    Voon V; Fernagut PO; Wickens J; Baunez C; Rodriguez M; Pavon N; Juncos JL; Obeso JA; Bezard E
    Lancet Neurol; 2009 Dec; 8(12):1140-9. PubMed ID: 19909912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyponatraemia and dopaminergic agents.
    Larner AJ
    Postgrad Med J; 1994 Apr; 70(822):310-1. PubMed ID: 7910397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.